# Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

> **NCT02859493** · NA · TERMINATED · sponsor: **Lesaffre International** · enrollment: 80 (estimated)

## Conditions studied

- Candidiasis, Vulvovaginal

## Interventions

- **DEVICE:** Saccharomyces cerevisiae
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02859493
- **Lead sponsor:** Lesaffre International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2017-03
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859493, "Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02859493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*